P

Peijia Medical Ltd
HKEX:9996

Watchlist Manager
Peijia Medical Ltd
HKEX:9996
Watchlist
Price: 4.99 HKD -2.73% Market Closed
Market Cap: 3.3B HKD
Peijia Medical Ltd
/
Income Statement
/
Revenue

Peijia Medical Ltd
Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Peijia Medical Ltd
Revenue Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Revenue CAGR 3Y CAGR 5Y CAGR 10Y
P
Peijia Medical Ltd
HKEX:9996
Revenue
¥615.5m
CAGR 3-Years
65%
CAGR 5-Years
101%
CAGR 10-Years
N/A
A
APT Medical Inc
SSE:688617
Revenue
¥1.7B
CAGR 3-Years
51%
CAGR 5-Years
47%
CAGR 10-Years
N/A
J
Jiangsu Yuyue Medical Equipment & Supply Co Ltd
SZSE:002223
Revenue
¥7.3B
CAGR 3-Years
1%
CAGR 5-Years
10%
CAGR 10-Years
16%
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
Revenue
¥37.1B
CAGR 3-Years
15%
CAGR 5-Years
19%
CAGR 10-Years
N/A
L
Lepu Medical Technology Beijing Co Ltd
SZSE:300003
Revenue
¥6.5B
CAGR 3-Years
-14%
CAGR 5-Years
-3%
CAGR 10-Years
15%
Shanghai United Imaging Healthcare Co Ltd
SSE:688271
Revenue
¥11.4B
CAGR 3-Years
26%
CAGR 5-Years
N/A
CAGR 10-Years
N/A

Peijia Medical Ltd
Glance View

Market Cap
3.4B HKD
Industry
Health Care

Peijia Medical Ltd. engages in the manufacture and sale of medical devices. The company is headquartered in Suzhou, Jiangsu. The company went IPO on 2020-05-15. Through its subsidiaries, the Company operates two segments. Transcatheter Valve Therapeutic Business segment is mainly engaged in the development of transcatheter valve therapeutic medical devices. Neurointerventional Business segment is engaged in the research and development of neurointerventional procedural medical devices. The firm's main products under development include TaurusOne, TaurusElite, TaurusNXT and others. The firm operates its businesses primarily in domestic market.

Intrinsic Value
11.05 HKD
Undervaluation 55%
Intrinsic Value
Price
P
What is Intrinsic Value?

See Also

What is Peijia Medical Ltd's Revenue?
Revenue
615.5m CNY

Based on the financial report for Dec 31, 2024, Peijia Medical Ltd's Revenue amounts to 615.5m CNY.

What is Peijia Medical Ltd's Revenue growth rate?
Revenue CAGR 5Y
101%

Over the last year, the Revenue growth was 40%. The average annual Revenue growth rates for Peijia Medical Ltd have been 65% over the past three years , 101% over the past five years .

Back to Top
ALPHA SPREAD
Follow us
Join more than 242,800+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.